2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Conditions
Neoplasms
5
Lung Neoplasms
3
Anxiety Disorders
3
Solitary Pulmonary Nodule
2
Paresthesia
2
Multiple Pulmonary Nodules
2
Hypesthesia
2
Dyspnea
2
Depression
2
Brain Neoplasms
2
Surgical Wound Infection
1
Skin Neoplasms
1
Radiation Injuries
1
Pulmonary Atelectasis
1
Prostatic Neoplasms
1
Prostatic Hyperplasia
1
Prostatic Diseases
1
Postoperative Complications
1
Pain
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia
1
Laparotomy
1
Inflammatory Bowel Diseases
1
Hypoxia
1
Hematologic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Therapeutics
31
Psychiatric Rehabilitation
27
Surveys and Questionnaires
15
Cognitive Behavioral Therapy
12
Early Intervention, Educational
10
Psilocybin
9
Ketamine
9
Methods
8
Saline Solution
7
Yoga
6
Mindfulness-Based Cognitive Therapy
6
Interviews as Topic
6
Esketamine
6
Counseling
6
Psychosocial Intervention
5
Mindfulness
5
Methylphenidate
5
Escitalopram
5
Educational Status
5
Behavior Therapy
5
Acupuncture Therapy
5
Palliative Care
4
Exercise Therapy
4
Exercise
4
Control Groups
4
Caregivers
4
Standard of Care
3
Psychotherapy
3
Niacin
3
Mindfulness-Based Stress Reduction
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Depression
×
Oxygen
×
Clear all
NCT06799351
2025-02-12
OzoParQTmicrob
Dr. Negrin University Hospital
Phase 2/3
Recruiting
42 enrolled
NCT06706544
2025-02-11
OzoParQT
Dr. Negrin University Hospital
Phase 2/3
Recruiting
42 enrolled